BioUtah News
-
Still on the Hill…
BioUtah continues to monitor issues of importance to our industry and engage with legislators on Utah’s Capitol Hill.
-
R-Zero Raises $105 Million Series C to Improve the Indoor Air We Breathe
R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals…
-
SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational
Facility will produce high-performance ceramic armor products for personnel, aircraft, and vehicles
-
SINTX Technologies Announces Closing of $12.0 Million Public Offering
SINTX Technologies Announces Closing of $12.0 Million Public Offering
-
BioUtah on Capitol Hill
The Utah State Legislature has hit its halfway point in the 2023 session. Since day one, BioUtah President…
-
US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System and its BIOFIRE® SPOTFIRE® Respiratory (R) Panel
US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System
-
Renalytix announces a c.$20.3 million private placement
Renalytix announces a c.$20.3 million private placement
-
Sumitomo Pharma Oncology Presented Preliminary Data From Phase 1/2 Clinical Study Evaluating Investigational Agent TP-3654 in Patients With Myelofibrosis at American Society of Hematology 2022 Annual Meeting & Exposition
Sumitomo Pharma Oncology presented new data from the ongoing Phase 1/2 study evaluating TP-3654.
-
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in Multiple Sclerosis by Sanofi
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company…
-
Quansys Biosciences launches new NHP line of Multiplex ELISA Assays
NHP-specific ELISAs now available from Quansys Biosciences
-
UTAH’S LIFE SCIENCES INDUSTRY TAKES TO THE HILL
Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of…
-
BIOMERICS COMPLETES CONNECTICUT EXPANSION
SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer in…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
